Brief: Crown Laboratories And Revance Announce Entry Into Merger Agreement

Revance Therapeutics

12/08/2024 14:04

Aug 12 (Reuters) - Revance Therapeutics Inc  RVNC.O :
    * CROWN LABORATORIES AND REVANCE ANNOUNCE ENTRY INTO MERGER
AGREEMENT
    * CROWN TO ACQUIRE REVANCE FOR $6.66 PER SHARE IN CASH
    * PROPOSED DEAL FOR TOTAL ENTERPRISE VALUE OF $924 MILLION
    * AFTER DEAL, CO'S STOCK WILL NO LONGER BE PUBLICLY TRADED
ON
NASDAQ

Source text for Eikon:  ID:nPn3fDzKqa 
Further company coverage:  RVNC.O 

 ((Reuters.Briefs@thomsonreuters.com;))